InDevR Raises $7 million in Series A Financing with Adjuvant Capital
Boulder, CO, 10 September 2019 – InDevR, Inc., a biotechnology [...]
Boulder, CO, 10 September 2019 – InDevR, Inc., a biotechnology [...]
Clinical validation of the FluChip-8G Influenza A+B Assay for influenza [...]
Analytical Evaluation of the Microarray-Based FluChip-8G Influenza A+B Assay published [...]
InDevR will be present at the ASM conference in [...]
InDevR receives 510(k) market clearance for the first influenza diagnostic [...]
+1 303-402-9100
6035 Longbow Dr., Suite 102, Boulder, CO, 80301
InDevR, Inc. ©2025 | Terms and Conditions | Privacy Statement
For Research Use Only. Not for use in diagnostic procedures.